Krystal Biotech Stock (NASDAQ: KRYS) stock price, news, charts, stock research, profile.
Open | $167.970 |
Close | $163.970 |
Volume / Avg. | 281.100K / 398.131K |
Day Range | 163.450 - 171.455 |
52 Wk Range | 82.090 - 189.970 |
Market Cap | $4.676B |
P/E Ratio | 421.000 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 43 |
Short Interest | 10.08% |
Days to Cover | 7.56 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Krystal Biotech (NASDAQ: KRYS) through any online brokerage.
Other companies in Krystal Biotech’s space includes: Immunovant (NASDAQ:IMVT), Legend Biotech (NASDAQ:LEGN), Ultragenyx Pharmaceutical (NASDAQ:RARE), Ionis Pharmaceuticals (NASDAQ:IONS) and Cerevel Therapeutics Hldg (NASDAQ:CERE).
The latest price target for Krystal Biotech (NASDAQ: KRYS) was reported by Stifel on Tuesday, April 16, 2024. The analyst firm set a price target for 204.00 expecting KRYS to rise to within 12 months (a possible 24.41% upside). 21 analyst firms have reported ratings in the last year.
The stock price for Krystal Biotech (NASDAQ: KRYS) is $163.97 last updated April 18, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Krystal Biotech.
Krystal Biotech’s Q1 earnings are confirmed for Monday, May 6, 2024.
There is no upcoming split for Krystal Biotech.
Krystal Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.